Biocon Biologics: Advancing Access to Affordable, High-Quality Biosimilars
Biocon Biologics: Advancing Access to Affordable, High-Quality Biosimilars
At Biocon Biologics, we are driven to improve patient lives by ensuring broader access to innovative, high-impact therapies. Through affordable biosimilars, we are overcoming treatment gaps, reducing healthcare challenges, and increasing care options to support better health outcomes globally.
Biosimilar Resource Hub
This platform is exclusively designed for healthcare professionals, highlighting the transformative potential of biosimilars across various therapeutic areas. Dive into a wealth of resources aimed at elevating patient care, optimizing treatment strategies, and driving innovation in global healthcare.
In the Spotlight
Audio Podcast
In this expert-led podcast, Dr. Jacob Siedlecki discusses real-world outcomes of biosimilar aflibercept in patients with neovascular age-related macular degeneration…
Video Podcast
Initiating Basal Insulin in Type 2 Diabetes
In this expert-led episode, Dr. Harpreet Bajaj discusses when and how to initiate basal insulin in type 2 diabetes. He…
This podcast discusses the role of personalized treat-and-extend (T&E) regimens in managing retinal diseases and how biosimilar aflibercept can be…
